ClinicalTrials.gg
CompletedNCT04827524Updated Jul 13, 2021

Investigation of Anthropometric Properties of Babies With Craniosynostosis

An observational study in Craniosynostoses, sponsored by Yuksek Ihtisas University. Completed at 1 site in Turkey. Open to participants aged 1 Month to 2 Years. Per ClinicalTrials.gov, last updated 2021-07-13.

Sponsored by Yuksek Ihtisas University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
1 Month to 2 Years
Sex
All
01

Study summary

Craniosynostosis is a malformation affecting the head and face, in which one or more sutures in the skull are fused prematurely. Premature union of one or more sutures causes changes in the shape of the skull base and dome, resulting in asymmetrical or restricted head and facial enlargement. It has been reported that in craniosynostosis, the bone enlargement is perpendicular to the fused sutures with the counterbalancing expansion. Craniosynostosis usually involves the union of a single cranial suture, but in some cases it has been observed that it may involve more than one suture in the baby's skull. An asymmetrical appearance is observed on the faces of babies, especially an unusual appearance in the form of eyes and skulls. It may present with neurological defects such as hydrocephalus, mental retardation, vision and hearing loss, as well as cosmetic deformities in the skull and facial bones. The general prevalence of craniosynostosis is around 1/2500 births. Generally, in single suture synostoses, there is no clear neurological finding except deformity. In multisuture synostoses there are a wide spectrum of findings such as increased intracranial pressure, hydrocephalus, syringomyelia, Chiari malformation, venous anomalies, ophthalmologic problems, growth retardation and epilepsy. Early diagnosis and treatment provides enough room for the baby's brain to grow and develop. It is thought that by measuring the anthropometric properties of these babies, the course of their development will be examined.

Read the detailed description

Babies diagnosed with craniosynostosis at birth will be included in this study. The patients will be diagnosed using a combination of physical examination, skull radiographs and 3 dimensional computerized tomography scans.A voluntary consent form will be signed by the parents of all subjects indicating that they are willing to participate in the study. Anthropometric measurements of all subjects will be measured with the Star Scanner device.

02

Conditions studied

  • Craniosynostoses

Browse trials for

03

In context

Craniosynostoses

51 studies on the registry are indexed under Craniosynostoses; 14 are open to participants now.

This study's enrollment of 30 is below the median of 43 across 26 observational studies indexed under Craniosynostoses.

Browse Craniosynostoses studies →

Lead sponsor

Yuksek Ihtisas University is the lead sponsor of 22 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 2 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

-Babies diagnosed with craniosynostosis at birth will be included in this study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being under 2 years old
  • Being diagnosed with non-syndromic craniosynostosis
  • Agreeing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Having a craniomaxillofacial fracture
  • Having a history of surgery
  • Having a congenital anomaly that affects growth or development
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No

Interventions

  • OtherAnthropometric measurement

    The demographic information and birth histories of the subjects included in the study will be taken first. Anthropometric measurements of all subjects will be measured with the Star Scanner device. The Star Scanner 3 dimensional data collection system is a scanning system that enables the anthropometric head measurements of the baby to be taken in just 2 seconds. The advantages of this device is that it does not emit any harmful beams during evaluation, it does not have any harmful effects on health, and that it is an application that will not disturb babies.

06

What researchers measure

Primary outcomes

  1. 3 dimensional anthropometric analysis of the cranium

    The 3 dimensional anthropometric analysis of the subjects cranium wil be measured using the Star Scanner device.

    Time frame: Change from baseline anthropometric measure at 3 months.

07

Study locations

1 site
  • Yuksek Ihtisas University
    Ankara, Çankaya 06650, Turkey
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to ethical reasons.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2020 to primary completion in Mar 2021, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 31, 2021
First posted
Apr 1, 2021
StartActual
Oct 1, 2020
Primary completionActual
Mar 30, 2021
CompletionActual
Apr 30, 2021
Last update
Jul 13, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04827524
Lead sponsor
Yuksek Ihtisas University
Responsible party
Melek Volkan Yazici (Principal Investigator, Yuksek Ihtisas University) — Principal investigator
First posted
Apr 1, 2021
Start date
Oct 1, 2020
Primary completion
Mar 30, 2021
Completion
Apr 30, 2021
Last update
Jul 13, 2021

Study contacts

Melek Volkan-Yazici, PhD
principal investigator · Yuksek Ihtisas University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion